Meeting Videos

Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse: Meeting 2 and Workshop 1

Session 4: Opioid Analgesics with Abuse-Deterrent Properties: Current Data and Future Opportunities (17:59 )

Speaker Presentations.

  • Welcome Richard Bonnie, L.L.B.
    Committee Chair

    Opening Remarks

Public Comment: Continued Discussion of Morning Sessions
Audience Discussion
HMD

Field questions from the audience.

Session 1: Moderator
David Clark, M.D., Ph.D.
Stanford University

Speaker Introductions.

Session 1: Non-Pharmacological Pain Management
David Shurtleff, Ph.D.
National Institute of Health

Speaker Presentation.

Session 1: Panel Q&A
Speakers
HMD

Panelist field questions from the audience.

Session 1: Pharmacological Pain Management, the Evolving...
James P. Rathmell, M.D.
Harvard University

Speaker Presentation.

Session 1: Response to the 2011 IOM Report Relieving Pain...
David A. Thomas, Ph.D.
National Institutes of Health Pain Consortium

Speaker Presentation.

Session 2: Barriers to and Facilitators of Discovery and...
William Schmidt, Ph.D.
NorthStar Consulting, LLC

Speaker Presentations.

Session 2: Identification of Targets for New Analgesics
Clifford Woolf, M.D., Ph.D.
Harvard University

Speaker Presentations.

Session 2: Moderator
Jose Moron-Concepcion, Ph.D.
Washington University

Speaker Introductions.

Session 2: Opioid Analgesia and Reward: Can They Be...
Howard Fields, M.D., Ph.D.
University of California, San Francisco

Speaker Presentations.

Session 2: Panel Q&A
Speakers
HMD

Panelist field questions from the audience.

Session 3: Harms and Consequences of Prescription Opioid...
Linda B. Cottler, Ph.D., M.P.H., F.A.C.E.
University of Florida

Speaker Presentations

Session 3: Intertwined Epidemics: Opioid- and...
Daniel Ciccarone, M.D., M.P.H.
University of California, San Francisco

Speaker Presentations

Session 3: Moderator
Lee Hoffer, Ph.D.
Case Western Reserve University

Speaker Introductions.

Session 3: Panel Q&A
Speakers
HMD

Panelist field questions from the audience.

Session 3: Prescription Drug Abuse in Rural Appalachia:...
Jennifer Havens, Ph.D., M.P.H.
University of Kentucky

Speaker Presentations

Session 4: Agonist Therapies for Treatment of Opioid...
Yngvild Olsen, M.D., M.P.H.
Institute for Behavioral Resources, Inc.

Speaker Presentations.

Session 4: Moderator
Traci Green, Ph.D., M.Sc.
Boston University

Speaker Introductions.

Session 4: Naloxone for Opioid Safety
Phillip Coffin, M.D., M.I.A.
San Francisco Department of Public Health

Speaker Presentations.

Session 4: Opioid Analgesics with Abuse-Deterrent...
Richard C. Dart, M.D., Ph.D.
Rocky Mountain Poison and Drug Center

Speaker Presentations.

Session 4: Panel Q&A
Speakers
HMD

Panelist field questions from the audience.

Session 4: Prescription Drug Monitoring Programs and Other...
Tamara M. Haegerich, Ph.D.
Centers for Disease Control and Prevention

Speaker Presentations.

Session 5: Cowan
Penney Cowan
American Chronic Pain Association

Speaker Presentations.

Session 5: Goyer
Jonathan Goyer
Anchor Recovery Community Center

Speaker Presentations.

Session 5: Moderator
Richard Bonnie, L.L.B.
University of Virginia

Speaker Introductions.

Session 5: Panel Q&A
Speakers
HMD

Panelist field questions from the audience.

Session 5: Raymond
Daniel Raymond
Harm Reduction Coalition

Speaker Presentations.

Session 5: Veasley
Christin Veasley
Chronic Pain Research Alliance

Speaker Presentations.

Welcome
Richard Bonnie, L.L.B.
Committee Chair

Opening Remarks

Study Staff

  • Morgan A. Ford, Study Director
  • View Full Study Staff Roster

    • Jonathan Phillips

    • Clare Stroud

    • Anne Claiborne

    • Thelma Cox

Activity Contact Information

For More Information Contact

Thelma Cox
Phone:
202-334-1734
E-mail:
opioids@nas.edu

Mailing Address


Keck Center
WS800
500 Fifth St. NW
Washington, DC 20001

Video Search